Tags » Antigen

Researchers to test whether Ebola survivors' blood can provide new treatment.

The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.  308 more words


The Appendix: Revisited

Antibody engineering and discovering new ways of treating diseases will never be obsolete as long as viruses and other harmful microorganisms continue to thrive and evolve. 438 more words


Chimeric antigen receptor T-cell (CART) therapy: current data, future potential

An article in today’s issue of the New England Journal of Medicine reports data from a Phase II trial of CART therapy¬†in the treatment of patients with acute lymphoblastic leukemia or ALL (an aggressive and difficult to treat form of cancer). 261 more words

Supersensitive nanodevice can detect extremely early cancers

October 5, 2014

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville (UAH) in collaboration with The Joint School of Nanoscience and Nanoengineering (JSNN) in Greensboro, NC.

880 more words

Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines.

The adenylate cyclase toxin-hemolysin (ACT, AC-Hly or CyaA) is a key virulence factor of Bordetella pertussis. It targets bactericidal activities of phagocytes, such as oxidative burst and complement- or antibody-mediated opsonophagocytic killing of bacteria. 133 more words


'Into the Dalek': a bit of science

This episode of Doctor Who saw the Doctor and Clara go “into darkness” – miniaturised and shoved inside a Dalek…

Photo: doctorwho-fans: Next up on…

498 more words